Google
STIM — NEURONETICS INC (Healthcare >> Medical Devices)
STIM FAQ
What is STIM's ROE?
NEURONETICS INC reports a Return on Equity (ROE) of -279.78%.
What is STIM's dividend yield?
NEURONETICS INC offers a dividend yield of 0.00%.
What is STIM's Deepscope Quality Score?
Deepscope rates STIM's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy STIM?
Deepscope's AI Timing Score for STIM is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does STIM belong to?
NEURONETICS INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 1.39
Price
-0.17
(-10.90%)
Day Change
|
|
|---|
STIM, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.39 |
| PBV / Sector |
6.36 / 7.31
|
| Earning Per Share | -0.48 |
| PE / Sector |
N/A / 28.52
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
3.88 M
GREAT
|
| Average 1W Daily Value |
3.10 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-04 09:23:56 |
| Symbol | STIM |
| Name | NEURONETICS INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 69.59 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 108.56 / 17,902.07 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3222 Phoenixville Pike, Malvern, PA, United States, 19355
Phone: 877 600 7555
Website: https://neurostar.com/neuronetics
Employees: 658
Sector: Healthcare >> Medical Devices
Description: Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
